Similar articles

• Management of recurrent colorectal cancer with positron emission tomography.

  Haji A. Haji A. Br J Hosp Med (Lond). 2007 Nov;68(11):580-3. doi: 10.12968/hmed.2007.68.11.27678. Br J Hosp Med (Lond). 2007. PMID: 18087843 Review.
• Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.

  Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpott GW, Kodner IJ. Ogunbiyi OA, et al. Ann Surg Oncol. 1997 Dec;4(8):613-20. doi: 10.1007/BF02303744. Ann Surg Oncol. 1997. PMID: 9416407
• [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer].

  Ito K, Kato T. Ito K, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 2002 May;62(6):270-7. Nihon Igaku Hoshasen Gakkai Zasshi. 2002. PMID: 12073633 Review. Japanese.
• Whole-body PET proves superior to CT for staging primary colorectal carcinoma.

  Ott DJ. Ott DJ. Am J Gastroenterol. 1999 Jan;94(1):285-6. doi: 10.1016/s0002-9270(98)00714-x. Am J Gastroenterol. 1999. PMID: 9934781 No abstract available.
• [PET/CT in colorectal cancer].

  Talbot JN. Talbot JN. Rev Prat. 2010 Oct 20;60(8):1074-7. Rev Prat. 2010. PMID: 21197736 French. No abstract available.